Objective. To describe the prevalence of abdominal aortic aneurysms (AAA) in patients with peripheral artery disease (PAD). Design. Observational, descriptive, transverse study. Patients and methods. We performed an abdominal ultrasound in 1190 consecutive patients with lower limb chronic ischemia (1/99-12/04). We registered cardiovascular risk factors and clinical data for analysis. Results. The ultrasound was inconclusive in 24 (2%) patients; 1166 patients completed the study. They were mostly male (93.7%), with an age mean of 67G9.9 years (37.7-93.4). The main cardiovascular risk factors were: smoking (80.9%), hypertension (41.7%) and hypercholesterolemia (31.4%). The prevalence of AAA was 13% (nZ151). Only 1.5% (nZ17) of the patients had a large AAA (O5 cm). The AAA was clearly more prevalent in men (nZ148; 13.6%) than in women (nZ 3; 4.1%) (RR 3.47; 95% CI 1.11-10.89; pZ0.02). The prevalence significantly increased with age, with a maximum of 17.1% in over 75-year-old men (pZ0.006). Patients with tibial disease had a significantly higher prevalence of AAA than aortoiliac or femoro-popliteal disease (pZ0.02).
Introduction
Peripheral artery disease (PAD) affects 8-10 million people in the USA. It is estimated that about 20% of the population over 70-years-old suffer from some degree of PAD. 1 Abdominal aortic aneurysms (AAA) are a frequent cause of death amongst adult males. 2 They account for about 9000 deaths in the USA annually, most of them occurring in men over 65 years of age. 3 AAA has been reported as the cause of death in about 2% of males over 60-years-old in Europe. 4, 5 If the AAA are left undiagnosed and untreated one third will eventually rupture. 3, 6 Early detection of these aneurysms is of the utmost importance. Elective surgical repair, with its low perioperative morbidity and mortality (under 3% in most published series 7, 8 ) would prevent the serious consequences of their rupture, whose global mortality can be as high as 90%. 9 The incidence of asymptomatic AAA, ruptured AAA and of age-standardized mortality has increased in several countries during the last few years, 6 possibly due to the rising life expectancy and to the development of easy and low-cost diagnostic tools like abdominal ultrasound. The prevalence varies depending on the population under study. Several recent population-based studies have established the prevalence of AAA as 4-9% in men older than 60 years, and 0.5-3% in over 80-year-old women. 3, 5, 10, 11 In contrast, patients suffering from PAD seem to be at particularly high-risk for the development of AAA, with an overall prevalence greater than 10%. 12 The objective of this study is to describe the prevalence and distribution of AAA in patients with PAD in the 300,000 population under our care.
Patients and Methods
From January 1999 to December 2004 we set-up a screening program for the detection of asymptomatic AAA in which we performed an abdominal ultrasound on 1190 consecutive patients who first visited our outpatient clinic and who were diagnosed with PAD. We classified the patients according to their age in various groups: !55, 55-64, 65-74 and O74 years. We registered the usual cardiovascular risk factors (tobacco use, hypertension, diabetes mellitus and hypercholesterolemia), and other comorbidities which could influence the development of an AAA like: chronic obstructive pulmonary disease (COPD), coronary artery disease (CAD), cerebrovascular disease, chronic renal failure, cancer, or family history of AAA.
We included both current and former smokers in the category of 'tobacco use'. Patients were regarded as hypertensive when they were receiving treatment (diet or medication) or their blood pressure was registered above 140/90 twice in basal conditions. We included complete blood tests in the study of all our patients. We used the consensus criteria for the diagnosis of diabetes mellitus (random blood glucose R126 mg/dl) or the patients were already being treated by an endocrinologist (diet, oral hypoglycaemics or insulin). We also used the standard criteria for the diagnosis of hypercholesterolemia (total basal cholesterol levels R200 mg/dl; LDL levels R100 mg/dl) or the patients were receiving specific medication or were under a supervised diet. COPD was diagnosed when maximal voluntary ventilation (MVV) was !80% or the patients were already under treatment. We routinely performed a carotid duplexscan on all the patients. We considered that cerebrovascular disease was present when we detected an asymptomatic significant (O50%) carotid stenosis or the patient had a positive history of minor or major stroke. We established the threshold for the presence of chronic renal failure when serum creatinine levels were R1.5 mg/dl. We registered the history of cancer because recent studies suggest the development of AAA are associated with serum TNF and C-reactive protein levels, which are increased in neoplasic processes. [13] [14] [15] [16] . PAD was diagnosed when the patient complained of ischemic symptoms and had an ankle-brachial index (ABI) !0.90. Pulse-volume recordings (PVR) with spectral analysis and ABI were recorded on all patients using a continuous, bidirectional Doppler, VASOFLOW 2 of QUERMED with 7.5 and 8.5 MHz transducers. We only performed a duplex-scan and/or magnetic resonance angiography when the patient suffered from incapacitating claudication or critical ischemia. We classified the level of PAD as aortoiliac, femoro-popliteal or tibial, depending on the location of the lesions. Patients with combined levels of ischemia were classified in the category of the most proximal level of the disease (i.e. aortoiliacCfemoropopliteal disease was classified as aortoiliac; femoro-poplitealCtibial disease was classified as femoro-popliteal). We used Fontaine's clinical categories of lower limb chronic ischemia: IIa-mild claudication; IIb-incapacitating claudication; IIIrest pain; IV-tissue loss.
Using a SONOLINE SL-2 ultrasound (SIEMENS) and a 3.5 Hz transducer, we measured the greatest transverse and antero-posterior outer diameters of the infrarenal abdominal aorta. All the scans were performed by two radiologists with extensive experience in this field. We used the definition of AAA by McGregor (R30 mm). 3, 17, 18 The aortas were classified in our study as normal (%26 mm), ectatic (27-29 mm) and aneurysmatic (R30 mm). Patients diagnosed with a !4 cm-diameter AAA were followed annually with an abdominal ultrasound. Aneurysms of 4-4.9 cm diameter were followed with a CT-scan every 6 months and AAA larger than 5 cm were electively repaired when there was no anaesthetic contraindication.
We performed a descriptive statistical analysis, using the values meanGstandard deviations for continuous variables and the number and percentage of patients for categorical variables. We used the chisquare test to compare nominal variables and independent-samples t-test for continuous variables. The patient information was entered into a Microsoft Excel 97 database and the statistical analysis was performed using the SPSS 10.0 software (www.spss.com). We accepted p!0.05 as significant.
Results
The radiologists were unable to accurately measure the aortic diameter in 24 (2%) of the 1190 ultrasounds performed because of a hostile abdomen, excessive bowel gas or obesity. The number of patients who finally completed the study was 1166. It took a mean time of 6G1.5 min to complete the diagnostic procedure. The mean aortic diameter of the 1166 patients was 22.2G7.4 mm (11-74). Fig. 1 shows the distribution of the aortic sizes. Almost 1000 (969; 83.1%) aortas were normal with a mean diameter of 19.6G 3.2 mm (11-26), 46 (3.9%) were ectatic with a mean diameter of 28.4G0.8 (27-29). We diagnosed 151 AAA with a mean diameter of 37.4G8.3 mm (30-74), equating to a prevalence of AAA in our patients with PAD of 13%. Only 17 (1.5%) patients had a R50 mm diameter ( Table 1) .
The patients studied were predominantly male (nZ 1093, 93.7%). AAA was clearly more prevalent in men (nZ148; 13.6%) than in women (nZ3; 4.1%), with a relative risk of 3.47 (95% CI 1.11-10.89, pZ0.02). The mean age at diagnosis was 67G9.9 years (range Table 2 and Fig. 2 . The prevalence significantly increases with the age of the patients (pZ0.006) ( Table 2 ). The main cardiovascular risk factors are detailed in Table 3 . Our patients with PAD and AAA have a significantly higher prevalence of hypertension (RR 1.85; 95% CI 1.31-2.62; p!0.0001), coronary artery disease (RR 1.64; 95% CI 1.07-2.52; pZ0.023), carotid artery disease (RR 1.82; 95% CI 1.18-2.79; pZ0.006), COPD (RR 1.63; 95% CI 1.1-2.42; pZ0.015) and chronic renal failure (RR 3.22; 95% CI 1.74-5.97; p!0.0001). In contrast, the presence of diabetes mellitus was a protective factor (RR 0.63; 95% CI 0.41-0.96; pZ 0.031). Smoking, hypercholesterolemia and a history of neoplasia had no association with the diagnosis of an AAA.
The commonest site of PAD was the femoropopliteal segment (58.2%). However, patients with tibial disease had the highest prevalence of AAA (19%), significantly higher than patients with aortoiliac (12.9%) and femoro-popliteal (11.3%) disease (pZ 0.02) ( Table 4 ). 93.4% (nZ1 089) of the patients suffered from intermittent claudication (grades IIa and IIb), and 12.9% (nZ140) of them were diagnosed with an AAA. The patients suffering from critical ischemia (grades III and IV), 6.6% (nZ77) of the patients in this study, had a prevalence of AAA of 14.3% (nZ11). The difference is not significant (pZ0.43) ( Table 5 ).
Discussion
The time required to complete an abdominal ultrasound and measure the infrarenal aortic diameter by qualified personnel is less than 10 min. 19 It is an accurate and reliable test, a simple and safe procedure in almost every patient, with a sensitivity and specificity in the detection of AAA of 95 and 100%, respectively. 3 Abdominal ultrasound is at present the most practical screening method for infrarenal AAA. 20 There is recent evidence that screening for AAA in the general population is worthwhile. Fleming reported that an invitation to screening was associated with a 43% reduction in AAA-related mortality in 65-75-year-old men. 3 Kim reported a reduction in AAArelated deaths by 42%, 21 and Wilmink reported a reduction in the incidence of ruptured AAA by 64%. 4 Implementation of a mass-screening program for AAA increased the life expectancy according to the Markov model in men over 60 years of age. 5 Early detection allows follow-up and reduces AAA-related mortality. The diagnosis of small AAA does not convey greater anxiety levels in the patients. 3 The introduction of a screening program would be expected to reduce the number of emergency operations by identifying patients with AAA before rupture and enabling elective surgery with lower risk of postoperative death. The number of elective operations is bound to increase initially and gradually stabilise. 22 Elective surgery conveys low mortality of 2-3% in most centers. The benefit of such a screening program is clear in our hospital.
According to Wilmink, screening for asymptomatic AAA can be cost-effective in populations with an incidence of ruptured AAA of O5/10,000 personyears. 4 The MASS study reported that the costeffectiveness of screening for AAA in the general population of men aged 65-74 years is, even at 4 years, A. Barba et al.
at the margin of acceptability according to current NHS thresholds, and it will improve substantially over a longer period. 17 The same and other authors have sustained that the cost-effectiveness of screening for AAA compares favourably with screening programs for other pathologies: the cost per life-year gained by screening for AAA is one third of the published cost per life-year gained by breast cancer or colorectal cancer screening and one eighth the cost for cervical cancer screening. 4, 6 To save one life the number of persons required to be screened for AAA is one tenth of those needed to be screened for breast cancer. 4, 5, 17 Screening for AAA appears worthwhile. The question is how to initiate it. If screening in the general population of older men seems to be beneficial in reducing AAA-related mortality and also cost-effective, this must be even more significant in a subgroup with a higher prevalence of AAA, such as patients with PAD whose prevalence of AAA is about twice that of the general population. Most AAA in our study (88.7%) have been detected when they were still small (107 AAA 30-39 mm, 27 AAA 40-49 mm), allowing for follow-up, surveillance and elective repair if they reach a R5 cm diameter.
The strong association of AAA with age has been well established both for men and women. The prevalence of AAA increases with age, with a maximum peak at age 80. 22 The prevalence in our young (!55 years) male patients was 5.4%, over 10% in men in their fifties, almost 15% in the sixth decade, and over 17% in men over 75-years-old. AAA are much less prevalent in women and occur about 10 years later in life compared to men. We found no AAA in under 75-year-old women suffering from PAD. However, even though the subgroup of women over 75 years of age was small in our study (nZ29), their prevalence of AAA was as high as 10.3%. These results do not justify the routine performance of an abdominal ultrasound in younger women with PAD. The screening program should only be performed in women in their seventies with PAD or associated risk factors. In the next few decades the distribution of cardiovascular risk factors and secondary cardiovascular diseases amongst women is likely to change significantly. New epidemiological studies will be essential in 30-40 years and the present recommendations will probably have to be revised. We have demonstrated a strong association between the presence of AAA and chronic renal failure in patients with PAD. AAA was also positively associated with hypertension, coronary artery disease, carotid artery disease and COPD, and negatively associated with diabetes mellitus. A more detailed multivariate analysis is required to be able to draw Brivady et al. 24 noted an association between AAA and aortoiliac occlusive disease and Galland 12 reported a higher association with femoro-popliteal disease. In our study, patients with tibial disease showed the highest prevalence of AAA. We do not have an explanation for this finding. We found no association between the degree of lower limb ischemia and the presence of AAA, similar to other authors. 24 Cost-effectiveness of a screening program can be increased if the screening is specifically targeted at a high-risk group. With the data obtained in our study, we can conclude that patients with PAD have a significantly higher prevalence of AAA than the general population, so they can be considered a high-risk group for the development of AAA. We believe it is necessary to perform an abdominal ultrasound in all male patients with PAD for the screening of AAA. Screening for AAA in women is, at the present time, more debatable, but we suggest introducing the program in older women with PAD.
